Synergene Therapeutics Inc
CAGE Code: 43DC1
NCAGE Code: 43DC1
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 072898005
Summary
Synergene Therapeutics Inc is an Active Commercial Supplier with the Cage Code 43DC1 and is tracked by Dun & Bradstreet under DUNS Number 072898005..
Address
1216 River Bay Rd
Annapolis MD 21409-4916
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Lockheed Martin Services Inc Superior Saw Service Inc P O Box Annapolis Performance Sailing, Rjm Associates Atlantic Telegraph And Mcis Corporation Wright, Nancy W Translations Chesapeake Technologies And Services Alliant Defense Electronics Systems Tower Technologies, Inc Eckert Optical Instruments Inc 9Th & Clinton, Llc Northrop Grumman Systems Corporation Sve Inc Howell Marine Inc Eastern Mountain Sports Wilkins Engineering Management Inc Endevco Corp Forerunners Group Llc
Frequently Asked Questions (FAQ) for CAGE 43DC1
- What is CAGE Code 43DC1?
- 43DC1 is the unique identifier used by NATO Organizations to reference the physical entity known as Synergene Therapeutics Inc located at 1216 River Bay Rd, Annapolis MD 21409-4916, United States.
- Who is CAGE Code 43DC1?
- 43DC1 refers to Synergene Therapeutics Inc located at 1216 River Bay Rd, Annapolis MD 21409-4916, United States.
- Where is CAGE Code 43DC1 Located?
- CAGE Code 43DC1 is located in Annapolis, MD, USA.
Contracting History for CAGE 43DC1 Most Recent 25 Records
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 5 Jul 2023
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $5,259,000.10
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 3 Jun 2021
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $3,151,240.70
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 15 May 2023
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $5,259,000.10
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 31 Mar 2021
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $3,151,240.70
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier. (Option Period 1)
- 6 Jul 2023
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier. (Option Period 1)
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $5,259,000.10
- Department Of Defense (Dod)